Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 25 studies | 30% ± 11% | |
pericyte | 21 studies | 31% ± 13% | |
smooth muscle cell | 16 studies | 24% ± 8% | |
myofibroblast cell | 8 studies | 26% ± 9% | |
connective tissue cell | 7 studies | 29% ± 19% | |
mesothelial cell | 5 studies | 32% ± 16% | |
adventitial cell | 4 studies | 31% ± 13% | |
podocyte | 3 studies | 50% ± 9% | |
retinal pigment epithelial cell | 3 studies | 45% ± 13% | |
myoepithelial cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of VASN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 5063.68 | 180 / 180 | 100% | 139.89 | 429 / 430 |
kidney | 100% | 6392.90 | 89 / 89 | 98% | 89.54 | 880 / 901 |
thymus | 98% | 3807.36 | 643 / 653 | 93% | 134.41 | 563 / 605 |
prostate | 91% | 2420.59 | 223 / 245 | 98% | 51.71 | 491 / 502 |
liver | 92% | 2140.06 | 209 / 226 | 95% | 52.12 | 386 / 406 |
breast | 98% | 4309.56 | 452 / 459 | 82% | 32.16 | 916 / 1118 |
uterus | 100% | 4176.43 | 170 / 170 | 77% | 48.19 | 353 / 459 |
lung | 100% | 5792.15 | 576 / 578 | 76% | 35.04 | 879 / 1155 |
skin | 99% | 9472.29 | 1785 / 1809 | 66% | 25.95 | 313 / 472 |
adrenal gland | 86% | 1864.44 | 223 / 258 | 75% | 42.92 | 172 / 230 |
bladder | 95% | 3469.14 | 20 / 21 | 56% | 21.17 | 284 / 504 |
esophagus | 75% | 2219.73 | 1081 / 1445 | 70% | 22.00 | 128 / 183 |
stomach | 50% | 1122.27 | 179 / 359 | 63% | 19.36 | 179 / 286 |
intestine | 60% | 1308.78 | 580 / 966 | 51% | 16.85 | 271 / 527 |
pancreas | 20% | 274.40 | 65 / 328 | 90% | 50.29 | 160 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.93 | 1 / 1 |
blood vessel | 100% | 13271.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 6314.03 | 1199 / 1204 | 0% | 0 | 0 / 0 |
spleen | 78% | 1580.71 | 189 / 241 | 0% | 0 | 0 / 0 |
heart | 71% | 1820.76 | 608 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 16.89 | 20 / 29 |
brain | 19% | 362.34 | 513 / 2642 | 34% | 14.19 | 238 / 705 |
tonsil | 0% | 0 | 0 / 0 | 51% | 10.27 | 23 / 45 |
eye | 0% | 0 | 0 / 0 | 38% | 7.27 | 30 / 80 |
muscle | 8% | 140.85 | 64 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0071461 | Biological process | cellular response to redox state |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0045296 | Molecular function | cadherin binding |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VASN |
Protein name | Vasorin (Protein slit-like 2) |
Synonyms | UNQ314/PRO357/PRO1282 SLITL2 |
Description | FUNCTION: May act as an inhibitor of TGF-beta signaling. . |
Accessions | Q6EMK4 ENST00000304735.4 ENST00000622615.1 |